Possibility of reducing blood loss during and after multiple birth

Cover Page


Cite item

Full Text

Abstract

Multiple pregnancy and multiple birth are pathologic obstetric situations. Recently occurrence of multiple pregnancy has increased due to increase of the age at planned pregnancy and widespread use of assisted reproductive technologies including in vitro fertilization. As a result clinicians practicing in obstetrics face more frequent multiple pregnancies, mostly twins. Risk of bleeding during multiple pregnancy, delivery and the postpartum period is estimated as high and is two times higher than in single pregnancy. The main causes of postpartum hemorrhage in multiple pregnancy are uterine hypotony or atony. Hemostatic changes occurring during pregnancy, unspecific and specific complications of multiple pregnancy are important as well. Correct management of the second period of a multiple vaginal delivery allows reducing the volume of blood loss. Method of fetal extraction in the intact amniotic sac allows reducing the influence of external factors on neonate’s head and the volume of blood loss during Cesarean section. Blood loss reducing is caused by amniotic sac compressing the vessels and therefore decreasing bleeding from the uterine incision for the time enough to extract the fetuses. Active management of the third period of vaginal delivery and afterbirth extraction with traction of umbilical cord during Cesarean section are crucial. Suggested regimens of uterotonics (oxytocin, carbetocin, misoprostol) and antifibrinolytics (tranexamic acid) reduce the risk of postpartum hemorrhage.

About the authors

N R Akhmadeev

Kazan State Medical University

Author for correspondence.
Email: akhmadeyevnr@gmail.com

F I Fatkullin

Kazan State Medical University

Email: akhmadeyevnr@gmail.com

G R Khayrullina

Kazan State Medical University

Email: akhmadeyevnr@gmail.com

N Yu Bystritskaya

City Clinical Hospital No.7

Email: akhmadeyevnr@gmail.com

References

  1. Ахмадеев Н.Р., Фаткуллин И.Ф. Извлечение плодов в целом плодном пузыре при двойне. Вестн. РУДН, серия Медицина. 2012; (6): 29-36.
  2. Мальцева Л.И., Зефирова Т.П., Абдуллина И.В. Значение препаратов антифибринолитического действия в профилактике акушерских кровотечений. Практ. мед. 2010; 4 (43): 83-85.
  3. Оказание медицинской помощи при одноплодных родах в затылочном предлежании (без осложнений) и в послеродовом периоде. Письмо Министерства здравоохранения Российской Федерации от 06.05.2014 №15-4/10/2-3185. http://www.ncagip.ru/upload/obrazovanie/rody_zad_2014.pdf (дата обращения: 17.09.2016).
  4. Кесарево сечение. Показания, методы обезболивания, хирургическая техника, антибиотикопрофилактика, ведение послеоперационного периода. Письмо Министерства здравоохранения Российской Федерации от 06.05.2014 №15-4/10/2-3190. http://www.ncagip.ru/upload/obrazovanie/kesareva_cecheniya_2014.pdf (дата обращения: 17.09.2016).
  5. Профилактика, лечение и алгоритм ведения при акушерских кровотечениях. Клинические рекомендации (протокол лечения). Письмо Министерства здравоохранения Российской Федерации от 29.05.2014 №15-4/10/2-3881. http://www.transfusion.ru/2015/06-19-2.pdf (дата обращения: 17.09.2016).
  6. Фаткуллин И.Ф., Ахмадеев Н.Р., Фаткуллин Ф.И. Кесарево сечение с извлечением плодов в целом плодном пузыре при беременности двойней. Акушерст. и гинекол. 2015; (6): 35-39.
  7. Alam A., Choi S. Prophylactic use of tranexamic acid for postpartum bleeding outcomes: A systematic review and meta-analysis of randomized controlled trials. Transfus. Med. Rev. 2015; 29 (4): 231-241. http://dx.doi.org/10.1016/j.tmrv.2015.07.002
  8. American College of Obstetricians and Gynecologists (ACOG). Postpartum hemorrhage. Washington (DC). American College of Obstetricians and Gynecologists (ACOG). 2006; 10 p.
  9. Arabin B., van Eyck J. Delayed-interval delivery in twin and triplet pregnancies: 17 years of experience in 1 perinatal center. Am. J. Obstet. Gynecol. 2009; 200 (2): 154 (e1-8). https://dx.doi.org/10.1016/j.ajog.2008.08.046
  10. Chowdhury S., Hussain M.A. Maternal complications in twin pregnancies. Mymensingh Med. J. 2011; 20 (1): 83-87.
  11. Elbohoty A.E., Mohammed W.E., Sweed M. et al. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. Int. J. Gynaecol. Obstet. 2016; 134 (3): 324-328. http://dx.doi.org/10.1016/j.ijgo.2016.01.025
  12. Macharey G., Ulander V.M., Kostev K. et al. Emergency peripartum hysterectomy and risk factors by mode of delivery and obstetric history: a 10-year review from Helsinki University Central Hospital. J. Perinat. Med. 2015; 43 (6): 721-728. http://dx.doi.org/10.1515/jpm-2013-0348
  13. Maged A.M., Hassan A.M., Shehata N.A. Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery in high risk women. J. Matern. Fetal. Neonatal. Med. 2016; 29 (4): 532-536. http://dx.doi.org/10.3109/14767058.2015.1011121
  14. Morikawa M., Yamada T., Turuga N. et al. Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies. J. Perinat. Med. 2006; 34 (5): 392-397. http://dx.doi.org/10.1515/JPM.2006.078
  15. National Collaborating Centre for Women’s and Children’s Health. Multiple pregnancy. The management of twin and triplet pregnancies in the antenatal period. London (UK): National Institute for Health and Clinical Excellence (NICE). 2011; 38 p.
  16. Novikova N., Hofmeyr G.J., Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database Syst. Rev. 2015; 16 (6): CD007872. http://dx.doi.org/10.1002/14651858.cd007872.pub3
  17. Pulmonary problems in pregnancy. Ed. G. Bourjeily, K. Rosen-Montana. Humana Press. 2009; 419 p.
  18. Santana D.S., Cecatti J.G., Surita F.G. et al. Twin pregnancy and severe maternal outcomes: The World Health Organization Multicountry Survey on Maternal and Newborn Health. Obstet. Gynecol. 2016; 127 (4): 631-641. http://dx.doi.org/10.1097/AOG.0000000000001338
  19. Simonazzi G., Bisulli M., Saccone G. et al. Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. Acta. Obstet. Gynecol. Scand. 2016; 95 (1): 28-37. http://dx.doi.org/10.1111/aogs.12798
  20. Smith-Levitin M., Skupski D.W., Chervenak F.A. Multifetal pregnancies: epidemiology, clinical characteristics and management. In: Clinical obstetrics. The fetus and mother. Ed. A.E. Reece, J.C. Hobbins. 3rd edition. Blackwell Publishing. 2007; Part IV (13): 177-202.
  21. Su L.L., Chong Y.S., Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst. Rev. 2012; 18 (4): CD005457. http://dx.doi.org/10.1002/14651858.cd005457.pub3
  22. Umazume T., Yamada T., Morikawa M. et al. Platelet reactivity in twin pregnancies. Thromb. Res. 2016; 138: 43-48. http://dx.doi.org/10.1016/j.thromres.2015.12.019
  23. Westhoff G., Cotter A.M., Tolosa J.E. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane Database Syst. Rev. 2013; 30 (10): CD001808. http://dx.doi.org/10.1002/14651858.cd001808.pub2
  24. Wetta L.A., Szychowski J.M., Seals S. et al. Risk factors for uterine atony/postpartum hemorrhage requiring treatment after vaginal delivery. Am. J. Obstet. Gynecol. 2013; 209 (1): 51 (e1-6).
  25. World Health Organization (WHO). WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva (Switzerland): World Health Organization (WHO). 2012; 41 p.
  26. Yamada T., Morikawa M., Yamada T. et al. Fibrinogen levels in the late stage of twin pregnancy. Thromb. Res. 2015; 135 (2): 318-321. http://dx.doi.org/10.1016/j.thromres.2014.11.030
  27. Young B.C., Wylie B.J. Effects of twin gestation on maternal morbidity. Semin. Perinatol. 2012; 36 (3): 162-168. http://dx.doi.org/10.1053/j.semperi.2012.02.007

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Akhmadeev N.R., Fatkullin F.I., Khayrullina G.R., Bystritskaya N.Y.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies